Michael Waisberg

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Plasmodium falciparum merozoite surface protein 1 blocks the proinflammatory protein S100P
    Michael Waisberg
    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA
    Proc Natl Acad Sci U S A 109:5429-34. 2012
  2. pmc Testing in mice the hypothesis that melanin is protective in malaria infections
    Michael Waisberg
    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America
    PLoS ONE 7:e29493. 2012
  3. pmc The impact of genetic susceptibility to systemic lupus erythematosus on placental malaria in mice
    Michael Waisberg
    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America
    PLoS ONE 8:e62820. 2013
  4. pmc Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria
    Ivo M B Francischetti
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America
    PLoS ONE 9:e87140. 2014
  5. pmc Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria
    Ivo M B Francischetti
    Section of Vector Biology, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Arterioscler Thromb Vasc Biol 32:786-98. 2012

Collaborators

Detail Information

Publications5

  1. pmc Plasmodium falciparum merozoite surface protein 1 blocks the proinflammatory protein S100P
    Michael Waisberg
    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA
    Proc Natl Acad Sci U S A 109:5429-34. 2012
    ....
  2. pmc Testing in mice the hypothesis that melanin is protective in malaria infections
    Michael Waisberg
    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America
    PLoS ONE 7:e29493. 2012
    ..Taken together, these results indicate that neither melanin nor vitamin D production improve survival in severe malaria...
  3. pmc The impact of genetic susceptibility to systemic lupus erythematosus on placental malaria in mice
    Michael Waisberg
    Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America
    PLoS ONE 8:e62820. 2013
    ..Thus, although SLE susceptibility was not protective in PM in mice it also did not have a negative impact on reproductive fitness...
  4. pmc Tempol, an intracellular antioxidant, inhibits tissue factor expression, attenuates dendritic cell function, and is partially protective in a murine model of cerebral malaria
    Ivo M B Francischetti
    Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America
    PLoS ONE 9:e87140. 2014
    ..The role of intracellular radical oxygen species (ROS) in pathogenesis of cerebral malaria (CM) remains incompletely understood...
  5. pmc Defibrotide interferes with several steps of the coagulation-inflammation cycle and exhibits therapeutic potential to treat severe malaria
    Ivo M B Francischetti
    Section of Vector Biology, Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
    Arterioscler Thromb Vasc Biol 32:786-98. 2012
    ..DF was investigated here as a drug to treat cerebral malaria...